RCMI Coordinating Center (RCMI CC) Header Logo

Connection

John Zhang to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications John Zhang has written about Drug Evaluation, Preclinical.
John Zhang
Connection Strength
0.067
Drug Evaluation, Preclinical
  1. Tsubokawa T, Solaroglu I, Yatsushige H, Cahill J, Yata K, Zhang JH. Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats. Stroke. 2006 Jul; 37(7):1888-94.
    View in: PubMed
    Score: 0.067
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support